Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minodronic Acid Monthly vs Daily in Involutional Osteoporosis
NCT00794443Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minodronic acid in osteoporosis, sponsored by Astellas Pharma. Started Nov 2008; status: completed.
02
Drugs
minodronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00794443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794443.